Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening
Vienna, Austria, November 12, 2020 /PRNewswire/ – Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the launch of a pioneering ultra-high-throughput SARS-CoV-2 test that




